
Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
AmeriSourceBergen introduces materials management system called Dimension21 to help hospitals control their inventory






